SCTBIO Trademark

Trademark Overview


On Wednesday, February 9, 2022, a trademark application was filed for SCTBIO with the United States Patent and Trademark Office. The USPTO has given the SCTBIO trademark a serial number of 79337464. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by SCTbio a.s.. The SCTBIO trademark is filed in the Treatment & Processing of Materials Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others

Labeling, relabeling, storage and distribution of cell therapy materials

Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies
sctbio

General Information


Serial Number79337464
Word MarkSCTBIO
Filing DateWednesday, February 9, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435168
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesManufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others
Goods and ServicesLabeling, relabeling, storage and distribution of cell therapy materials
Goods and ServicesPharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSCT CELL MANUFACTURING S.R.O.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCZ-170 00 PRAGUE 7
CZ

Party NameSCT CELL MANUFACTURING S.R.O.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCZ-170 00 PRAGUE 7
CZ

Party NameSCT CELL MANUFACTURING S.R.O.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCZ-170 00 PRAGUE 7
CZ

Party NameSCTbio a.s.
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressCZ

Trademark Events


Event DateEvent Description
Tuesday, April 12, 2022APPLICATION FILING RECEIPT MAILED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 22, 2022ASSIGNED TO EXAMINER
Wednesday, November 23, 2022NON-FINAL ACTION WRITTEN
Thursday, November 24, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 25, 2022CHANGE OF OWNER RECEIVED FROM IB
Friday, January 20, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 25, 2023REFUSAL PROCESSED BY MPU
Wednesday, January 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Monday, August 14, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 14, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 14, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, October 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 13, 2023TEAS PETITION TO REVIVE RECEIVED
Friday, October 13, 2023PETITION TO REVIVE-GRANTED
Friday, October 13, 2023NOTICE OF REVIVAL - E-MAILED
Friday, October 13, 2023NOTICE OF REVIVAL - E-MAILED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ASSIGNED TO LIE
Tuesday, March 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 20, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 22, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, December 13, 2024FINAL DISPOSITION PROCESSED
Tuesday, August 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, January 4, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 13, 2024FINAL DISPOSITION NOTICE SENT TO IB